Amphastar Pharmaceuticals, Inc. 10-K filing
Filed 2026-02-26 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001297184-26-000009
- Form type
- 10-K
- CIK
- 0001297184
- Primary document
- https://www.sec.gov/Archives/edgar/data/1297184/000129718426000009/amph-20251231x10k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Amphastar Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $719.9M | - | - |
| Cost Of Revenue | $363.8M | - | - |
| Gross Profit | $356.1M | - | - |
| Operating Income | $140.4M | - | - |
| Net Income | $98.1M | - | - |
| Eps Basic | 2.1 | - | - |
| Eps Diluted | 2.03 | - | - |
| Cash And Equivalents | $170.2M | - | - |
| Total Assets | $1.6B | - | - |
| Total Liabilities | $840.5M | - | - |
| Operating Cash Flow | $156.1M | - | - |
| Capital Expenditures | $34.9M | - | - |